Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings.
Trishul SiddharthanNicole M RobertsonNatalie A RykielLindsay J UnderhillNihaal RahmanSujan KafleSakshi MohanRoma PadalkarSarah McKeownOscar Flores-FloresShumonta A QuaderiPatricia AlupoRobert KalyesubulaBruce KirengaJing LuoMaria Kathia CárdenasGonzalo GianellaJ Jaime MirandaWilliam CheckleyJohn R HurstSuzanne L PollardPublished in: PLOS global public health (2022)
The availability and pricing of respiratory medications varied across LMIC settings, with medications for acute care of respiratory diseases being more widely available than those for long-term management.